Found 6 matching trials
A Study of GV20-0251 in Advanced or Refractory Solid Tumors PHASE1 This is a single-arm, single-center study for multiple tumor indications to...
Show More Location
West China Hospital
Learn More & Join Trial
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. PHASE2 This is a Phase 2 study of GV20-0251 in combination with anti-PD-1 monoclon...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Study of GV20-0251 in Participants With Solid Tumor Malignancies PHASE1 This is a Phase 1 and Phase 2 study of GV20-0251 being developed for the tr...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) PHASE1 The goal of this Phase I/II observational and interventional platform study...
Show More Location
Multiple Locations
Learn More & Join Trial
GV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study PHASE1 The goal of this clinical trial is to learn whether neoadjuvant GV20-0251 c...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies PHASE1 This is a Phase 1/2A study of GV20-0251 being developed for the treatment o...
Show More Location
The Angeles Clinic and Research Institute
Learn More & Join Trial